Literature DB >> 23761622

Prospective study of restless legs syndrome and mortality among men.

Yanping Li1, Wei Wang, John W Winkelman, Atul Malhotra, Jing Ma, Xiang Gao.   

Abstract

OBJECTIVE: To prospectively examine whether men with restless legs syndrome (RLS) had an increased risk of mortality.
METHOD: This was a prospective cohort study of 18,425 US men free of diabetes, arthritis, and renal failure in the Health Professionals Follow-up Study (HPFS). In 2002, RLS was assessed using a set of standardized questions. Deaths were identified from state vital statistics records, the National Death Index, family reports, and the postal system.
RESULTS: During 8 years of follow-up (2002-2010), we documented 2,765 deaths. In an age-adjusted model, RLS was associated with a 39% increased risk of mortality (hazard ratio [HR] = 1.39; 95% confidence interval [CI] 1.19-1.62; p < 0.0001). The association between RLS and mortality was slightly attenuated after further adjustment for body mass index, lifestyle factors, chronic conditions, sleep duration, and other sleep-related disorders (adjusted HR = 1.30; 95% CI 1.11-1.52; p = 0.003). When we further excluded those with major chronic conditions (e.g., cancer, high blood pressure, cardiovascular disease, and other comorbidities), the adjusted HR was 1.92 (95% CI 1.03-3.56; p = 0.04). The interactions between RLS and other risk factors (older age, overweight, short sleep duration, smoking, low physical activity, and unhealthy diet) in relation to total mortality risk were not significant (p for interaction >0.2 for all).
CONCLUSION: We observed that men with RLS had a higher overall mortality and this association was independent of known risk factors. The increased mortality in RLS was more frequently associated with respiratory disease, endocrine disease, nutritional/metabolic disease, and immunologic disorders. Future research exploring the pathophysiologic relationship between these disorders and RLS is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23761622      PMCID: PMC3770202          DOI: 10.1212/WNL.0b013e318297eee0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Restless legs syndrome and Parkinson's disease in men.

Authors:  Xiang Gao; Michael A Schwarzschild; Eilis J O'Reilly; Hao Wang; Alberto Ascherio
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics").

Authors:  Wayne A Hening; Richard P Allen; Mystinna Washburn; Suzanne R Lesage; Christopher J Earley
Journal:  Sleep Med       Date:  2009-01-29       Impact factor: 3.492

3.  Coffee consumption and mortality in women with cardiovascular disease.

Authors:  Esther Lopez-Garcia; Fernando Rodriguez-Artalejo; Tricia Y Li; Kenneth J Mukamal; Frank B Hu; Rob M van Dam
Journal:  Am J Clin Nutr       Date:  2011-05-11       Impact factor: 7.045

4.  Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population.

Authors:  L Mallon; J E Broman; J Hetta
Journal:  J Intern Med       Date:  2002-03       Impact factor: 8.989

Review 5.  Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies.

Authors:  Francesco P Cappuccio; Lanfranco D'Elia; Pasquale Strazzullo; Michelle A Miller
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

6.  Restless legs syndrome in end-stage renal disease.

Authors:  J W Winkelman; G M Chertow; J M Lazarus
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

7.  Iron status and restless legs syndrome in the elderly.

Authors:  S T O'Keeffe; K Gavin; J N Lavan
Journal:  Age Ageing       Date:  1994-05       Impact factor: 10.668

8.  Evaluating adherence to recommended diets in adults: the Alternate Healthy Eating Index.

Authors:  Marjorie L McCullough; Walter C Willett
Journal:  Public Health Nutr       Date:  2006-02       Impact factor: 4.022

Review 9.  Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.

Authors:  Alex Iranzo; Cynthia L Comella; Joan Santamaria; Wolfgang Oertel
Journal:  Mov Disord       Date:  2007       Impact factor: 10.338

10.  Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.

Authors:  Shahrad Taheri; Ling Lin; Diane Austin; Terry Young; Emmanuel Mignot
Journal:  PLoS Med       Date:  2004-12-07       Impact factor: 11.069

View more
  27 in total

1.  Sleep Disorders and Attention Deficit: A Consequence of Proinflammatory State?

Authors:  Mengühan Araz Altay
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

2.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

3.  Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD.

Authors:  Hyatt Moore; Juliane Winkelmann; Ling Lin; Laurel Finn; Paul Peppard; Emmanuel Mignot
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

4.  Restless legs syndrome in non-dialysis renal patients: is it really that common?

Authors:  Jesús Calviño; Secundino Cigarrán; Luis M Lopez; Agustin Martinez; Maria-Jesús Sobrido
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

5.  Association of incident restless legs syndrome with outcomes in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Jun L Lu; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Sleep Res       Date:  2016-02       Impact factor: 3.981

6.  Prevalence of restless legs syndrome during detoxification from alcohol and opioids.

Authors:  Susan E Mackie; R Kathryn McHugh; Katherine McDermott; Margaret L Griffin; John W Winkelman; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2016-10-06

7.  Restless legs syndrome in maintenance hemodialysis patients: an epidemiologic survey in Hefei.

Authors:  Jian-Ping Xiao; Gui-Xia Zhang; Lei Chen; Ben-Gui Sun; Hong-Xu Zhang; Li-Hong Chen; Liang Yuan; Li Hao; De-Guang Wang
Journal:  Int Urol Nephrol       Date:  2017-03-28       Impact factor: 2.370

8.  Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.

Authors:  Stephen K Van Den Eeden; Kathleen B Albers; Julie E Davidson; Clete A Kushida; Amethyst D Leimpeter; Lorene M Nelson; Rita Popat; Caroline M Tanner; Kristen Bibeau; Charles P Quesenberry
Journal:  Sleep       Date:  2015-07-01       Impact factor: 5.849

9.  Plasma apelin level in patients with restless legs syndrome and its association with periodic leg movements.

Authors:  Selda Korkmaz; Murat Aksu; Gulden Baskol
Journal:  Sleep Breath       Date:  2016-05-19       Impact factor: 2.816

10.  Restless legs syndrome status as a predictor for lower physical function.

Authors:  Chunbai Zhang; Yanping Li; Atul Malhotra; Yi Ning; Xiang Gao
Journal:  Neurology       Date:  2014-03-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.